Improvement of recurrence-free survival after radical prostatectomy for locally advanced prostate cancer in relation to the time of surgical intervention

被引:1
|
作者
Veliev, E. I. [1 ,2 ]
Sokolov, E. A. [1 ,2 ]
Loran, O. B. [1 ]
机构
[1] Russian Med Acad Postgrad Educ, Dept Urol & Operat Androl, 2-1 Barrikadnaya St, Moscow 125995, Russia
[2] SP Botkin City Clin Hosp, 5 Second Botkinsky Passage, Moscow 125284, Russia
来源
ONKOUROLOGIYA | 2016年 / 12卷 / 01期
关键词
prostate cancer; radical prostatectomy; biochemical recurrence; surgical margin; recurrence-free survival; high risk; surgery time; locally advanced process; stage T3; prostate-specific antigen;
D O I
10.17650/1726-9776-2016-12-1-69-73
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: to comparatively estimate the frequency of a positive surgical margin and 5-year biochemical recurrent-free survival (BRFS) rates in patients with locally advanced prostate cancer in relation to the time of radical retropubic prostatectomy. Subjects and methods. The investigation enrolled 274 patients with prostate cancer (pT3-4N0-1M0) who were divided into 2 groups of 68 and 20 patients operated on in 1997 to 2006 and 2007 to 2012, respectively. Two surgeons made surgical interventions by the standardized procedure. The 5-year BRFS rates were estimated using the Kaplan-Meier method and log-rank test. A biochemical recurrence was defined as a prostate-specific antigen level of >= 0.2 ng/ml in 2 consecutive measurements or as the initiation of adjuvant therapy. Results. The detection rate of a positive surgical margin decreased from 55.9 % in 1997-2006 to 37.9 % in 2007-2012 (p = 0.01); the 5-year recurrence-free survival rates were 38.8 % versus 66.2 % (p < 0.001). Conclusion. These changes would probably be a result of surgeons" better experience and improved surgical techniques in the course of time.
引用
收藏
页码:69 / 73
页数:5
相关论文
共 50 条
  • [21] Recurrence-free Survival after radical Prostatectomy and PDE-5 Inhibitor Intake
    Hofer, L.
    Radtke, J. P.
    Rapp, C.
    Pahernik, S.
    Teber, D.
    Hohenfellner, M.
    Hadaschik, B.
    UROLOGE, 2017, 56 (04): : 492 - 496
  • [22] PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy
    Emily Eva Holmes
    Diane Goltz
    Verena Sailer
    Maria Jung
    Sebastian Meller
    Barbara Uhl
    Jörn Dietrich
    Magda Röhler
    Jörg Ellinger
    Glen Kristiansen
    Dimo Dietrich
    Clinical Epigenetics, 2016, 8
  • [23] Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy
    Wang, Li
    Xie, Pei-Gen
    Lin, Ying-Li
    Ma, Jian-Guo
    Li, Wen-Ping
    MEDICAL SCIENCE MONITOR, 2014, 20
  • [24] A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy
    Shi, Run
    Bao, Xuanwen
    Weischenfeldt, Joachim
    Schaefer, Christian
    Rogowski, Paul
    Schmidt-Hegemann, Nina-Sophie
    Unger, Kristian
    Lauber, Kirsten
    Wang, Xuanbin
    Buchner, Alexander
    Stief, Christian
    Schlomm, Thorsten
    Belka, Claus
    Li, Minglun
    CANCERS, 2020, 12 (01)
  • [25] PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy
    Holmes, Emily Eva
    Goltz, Diane
    Sailer, Verena
    Jung, Maria
    Meller, Sebastian
    Uhl, Barbara
    Dietrich, Joern
    Roehler, Magda
    Ellinger, Joerg
    Kristiansen, Glen
    Dietrich, Dimo
    CLINICAL EPIGENETICS, 2016, 8
  • [26] Prognostic factors of biochemical recurrence after radical prostatectomy for localized and locally-advanced prostate cancer
    Chernyaewl, V. A.
    Matreev, V. B.
    Volkova, M. L.
    Nikilarova, Z. N.
    Sherchenko, V. E.
    ONKOUROLOGIYA, 2012, 8 (04): : 58 - 64
  • [27] Prognostic factors of biochemical recurrence after radical prostatectomy for localized and locally-advanced prostate cancer
    Chernyaev, V.
    Matveev, B.
    Volkova, M. I.
    Nikiforova, Z. N.
    Shevchenko, V. E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S21 - S21
  • [28] Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy
    Takuya Koie
    Chikara Ohyama
    Shingo Hatakeyama
    Atsushi Imai
    Takahiro Yoneyama
    Yasuhiro Hashimoto
    Tohru Yoneyama
    Yuki Tobisawa
    Shogo Hosogoe
    Hayato Yamamoto
    Masato Kitayama
    Kazuyoshi Hirota
    International Journal of Clinical Oncology, 2016, 21 : 379 - 383
  • [29] Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy
    Koie, Takuya
    Ohyama, Chikara
    Hatakeyama, Shingo
    Imai, Atsushi
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Yoneyama, Tohru
    Tobisawa, Yuki
    Hosogoe, Shogo
    Yamamoto, Hayato
    Kitayama, Masato
    Hirota, Kazuyoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (02) : 379 - 383
  • [30] SIGNIFICANCE OF PREOPERATIVE BUTYRYLCHOLINESTERASE AS AN INDEPENDENT PREDICTOR OF BIOCHEMICAL RECURRENCE-FREE SURVIVAL IN PATIENTS WITH PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY
    Koie, Takuya
    Ohyama, Chikara
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Yoneyama, Tohru
    Tobisawa, Yuki
    JOURNAL OF UROLOGY, 2016, 195 (04): : E238 - E238